Head and Neck Cancer Perspective

 
 
  • The Many Forms of HPV: Recognition and Management Through a series of short cases, Dr Gordon Sun addresses the recognition and early assessment of patients with suspected HPV-related disease and cancers.
  • How a Cancer Doctor Really Feels About Second Opinions Private-practice radiation oncologist Andrew Neuschatz talks about the nuances of second opinions in oncology.
  • Top News From ESMO 2018: Slideshow Practice changing data on prostate cancer, new hope in triple negative breast cancer and the potential for chemo-free head and neck cancer therapy featured prominently this year.
  • How the 2018 WCLC Data Change Lung Cancer Practice The 19th World Conference on Lung Cancer (WCLC), held September 23-26 in Toronto, featured a remarkable presidential session that included multiple practice-changing results.
  • ATA 2018 Read clinically focused news coverage of key developments from American Thyroid Association (ATA) 2018
  • Glioblastoma Knowledge Shot   On August 25th, 2018, Senator John McCain died after battling with glioblastoma. Here is a quick look at what makes glioblastomas so deadly.
  • Malpractice Case: Are You Sure the Patient Received the Test Results? This case shows why it is crucial for physicians to have a fail-safe plan to contact patients to discuss any test results.
  • Artificial Intelligence in Cancer Care: 5 Things to Know From detecting cancer to recommending treatments, artificial intelligence is poised to improve cancer care in myriad ways.
  • Headache MRI: What to Do With Incidental Findings Dr Randolph Evans reviews the prevalence and types of significant incidental findings on brain MRI for headaches.
  • The Thyroid Diet: Is There Such a Thing? From gluten to soy to iodine to selenium, patients are asking about 'thyroid diets.' What is the evidence on nutrition and thyroid health?
  • Non-Hispanic White Patients Have Higher Glioma Incidence Dr Laurie Barclay comments on a study that aimed to quantify the differences in incidence and survival in adults with glioma by race or ethnicity.
  • 'An Inconvenient Truth': Add Bev or Chemo to TKIs in Lung Cancer   What agents can you combine with a TKI to improve progression-free survival in EGFR-mutant lung cancer? Dr Mark Kris discusses recent data from ASCO on this topic.
  • What Is the Best Approach to Managing 'Chemobrain'? Experts discuss the poorly understood but common experience of 'chemobrain' in cancer patients, including the evidence behind interventions to reduce the symptoms.
  • Four New Studies in Neurology   Dr Diener reviews four studies likely to change the practice of neurology that encompass PFO closure in cryptogenic stroke, new treatments for migraine and glioblastoma, and tried-and-true treatments for MS.
  • Surgeon Volume and Impact on Esophagectomy Outcomes Dr Lowenfels comments on a study that examines whether operation-specific volume and surrogate volume are significant predictors of in-hospital mortality for esophagectomy.
  • Top News From ASCO 2018: Slideshow Highlights include practice-changing data in advanced non-small cell lung cancer, early breast cancer, and kidney cancer, plus welcome news of $10 million in new funding for research.
  • Refining the Management of Recurrent Glioblastoma From the AAN Annual Meeting, Medscape speaks with Dr Sushma Bellamkonda about her research on factors that improve treatment response in patients with glioblastoma.
  • A 48-Year-Old Woman With a Thyroid Mass: USMLE Question A 48-year-old woman presents with an asymptomatic thyroid mass. Can you make the diagnosis?
  • Which Patients With CNS Metastases Can Avoid Radiation?   Thoracic oncologists Drs Jack West and Hossein Borghaei talk about the CNS activity of new lung cancer agents and whether it means some patients can forgo radiotherapy.
  • ASCO 2018Top 5 Lung Cancer Presentations at ASCO 2018 Thoracic oncologist Dr Jack West discusses the five most important and clinically relevant abstracts to be presented at the upcoming ASCO 2018 annual meeting.